Oncology & Cancer

Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma

Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients' T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn't work well in every cancer—including ...

Oncology & Cancer

Q&A: Combating prostate cancer stigma

When U.S. Defense Secretary Lloyd Austin was diagnosed with prostate cancer, his illness was largely kept quiet from the public. Though Austin faced scrutiny for not being more forthcoming about his health, experts like Daniela ...

Medications

New cell-based immunotherapy offered for melanoma

Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.

page 2 from 40